Blood cancers

Podcast: Reassessing treatment goals for CLL in the era of targeted therapies

Sponsored by Janssen-Cilag Pty Ltd

A better understanding of the biology of chronic lymphocytic leukaemia (CLL) has led to significant improvements in treatment strategies and outcomes for patients with CLL. In this podcast, we talk to Professor Peter Hillmen from the University of Leeds about how the introduction of novel therapies for CLL has influenced treatment goals. He also provides ...

Already a member?

Login to keep reading.

© 2021 the limbic